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Intracervical Foley catheter for induction of labour
Labour is induced in about 20% of pregnant women 
in high-income countries, making it one of the most 
frequently done obstetric interventions.1,2 Induction is 
commonly oﬀ ered to women at 41 weeks’ gestation 
or greater, to reduce the risk of perinatal death.3 
Induction is also indicated in suspected maternal or fetal 
compromise, such as pregnancy-induced hypertension 
at term, for which delivery is likely to improve maternal 
or fetal health.4
The optimum method of induction of labour is uncertain. 
Vaginal or intracervical prostaglandins are used in the 
UK and USA. Alternatives include mechanical methods, 
such as forewater amniotomy, laminaria tents, or an 
intracervical Foley catheter; all these methods probably 
stimulate endogenous prostaglandin production, thus 
ripen ing the cervix. Externally administered prostaglan-
dins are eﬀ ective at cervical ripening and hastening deliv-
ery, but increase the risk of uterine hyperstimulation with 
fetal heart rate changes.5 In nulliparous women or women 
with previous vaginal deliveries, there is no evidence 
that prostaglandin-induced uterine hyperstimulation is 
associated with substantial harm, since prostaglandins do 
not increase the risk of caesarean section or neonatal unit 
admission.5 However, in women with a previous caesarean 
section, induction with prostaglandins is associated 
with uterine rupture.6 The absolute risk is small, but the 
potential for perinatal death leads to caution about use of 
prostaglandins in this situation.7,8
When labour onset occurs physiologically, the cervix 
ripens before myometrial contractions start. A major 
draw back of administered prostaglandins is that they 
aﬀ ect both cervical ripening and contractions simul-
taneously. Contractions occurring before the cervix is ripe 
are not eﬀ ective in progressing labour and merely restrict 
blood ﬂ ow to the fetus. We and others have proposed 
that the ideal strategy for induction would be adminis-
tra tion of a cervical ripening agent before stimulation of 
con tractions,9,10 which would decrease the need for fetal 
monitoring during ripening (enabling outpatient use) 
and reduce the risk of uterine rupture. Although nitric 
oxide donors induce cervical ripening without inducing 
uterine contractions,11 they do not hasten the onset of 
delivery or reduce the need for additional agents when 
used for induction of labour.12,13 By contrast, in The Lancet 
Marta Jozwiak and colleagues14 show that intracervical 
placement of a Foley catheter induces cervical ripening 
without inducing uterine contractions and is as successful 
as prostaglandin for induction of labour, according to the 
number of failed inductions and caesarean section rates.
The researchers randomly assigned 824 women 
to either induction of labour with a Foley catheter or 
prostaglandin E2 (up to 3 mg). If cervical ripening had not 
been achieved by 48 h, the woman rested for a day and 
then had a single repeat treatment. Once the cervix had 
ripened, induction of labour was continued with forewater 
amniotomy and oxytocin infusion. The rate of caesarean 
section (the primary outcome) was much the same in 
both groups (93 [23%] for Foley catheter vs 82 [20%] 
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for prostaglandins, relative risk 1·13, 95% CI 0·87–1·47, 
p=0·38). Although the induction-to-delivery interval 
and rates of caesarean section for failure to progress in 
the ﬁ rst stage of labour both increased, women in the 
Foley catheter group had reduced rates of both operative 
delivery for fetal distress and neonatal unit admission. 
In a meta-analysis, the investigators show that Foley 
catheter induction is similar to prostaglandin induction 
for caesarean section rate but signiﬁ cantly reduces rates 
of hyperstimulation (odds ratio 0·44, 95% CI 0·21–0·91) 
and postpartum haemorrhage (0·60, 0·37–0·95). 
Although women’s views of the Foley catheter were not 
formally assessed, 74% of eligible women approached 
agreed to participate in the trial, and less than 0·5% 
declined when allocated to the Foley catheter, implying 
high pretreatment acceptability.
These data suggest that Foley catheter induction of 
labour is eﬀ ective and should be considered for use 
in clinical practice. Some authorities caution against 
mechanical methods of cervical ripening or induction of 
labour because of the perceived increased risk of infection.7 
Jozwiak and colleagues report no evidence of increased 
infection for either mothers or babies, and these data 
should prompt a revision of the recommendation that 
“mechanical procedures (balloon catheters and laminaria 
tents) should not be used routinely for induction of 
labour”.7 The low cost of the Foley catheter could make it 
particularly useful in resource-limited settings.
Jozwiak and co-workers’ study makes an important 
contribution. The nature of Foley catheter treatment 
means that it would not have been easy to conceal 
treatment allocation; however, despite the open-label 
design, the randomisation procedure was suﬃ  ciently 
robust to prevent treatment allocation bias. Important 
questions remain about the design of trials to test 
interventions for labour induction. The Cochrane 
collaboration suggests ﬁ ve potential primary outcomes 
for induction agents: vaginal delivery not being achieved 
within a speciﬁ ed time, caesarean section, uterine 
hyperstimulation with fetal heart rate changes, serious 
neonatal morbidity or mortality, and serious maternal 
morbidity or mortality.15 In practice one primary out-
come is often used, commonly (as here) caesarean 
section. By this measure, the Foley catheter was no 
better than prostaglandin. However, the reduced risk of 
hyperstimulation with the Foley catheter (a secondary 
outcome of Jozwiak and co-workers’ study) is likely to be 
attractive to pregnant women (particularly those with 
a previous caesarean section) and clinicians. Although 
women with a previous caesarean section were excluded 
from Jozwiak and colleagues’ study, a Foley catheter 
could be the ideal induction agent in this situation, 
and should be assessed further in randomised trials. 
If such trials are to be done, the avoidance of maternal 
and neonatal mortality and morbidity are arguably as 
important as speed and avoidance of caesarean section, 
and warrant inclusion as primary outcomes.
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